Researchers screened 5,000 Food and Drug Association-approved drugs to identify repurposed drugs targeting SARS-CoV-2 spike protein cleavage at both S1/S2 boundary and S2’.

New Capabilities Empower Gene Therapy Developers to Explore a Broader Range of Vector Designs and Rapidly Identify Candidates Best Poised for IND Speed and Success SAN FRANCISCO, CA / ACCESSWIRE / May ...

In silico drug design, paired with predictive ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) modeling, has emerged as a powerful tool, streamlining the path from virtual ...

AG Moerschbacher - NewsDenis Qoray successfully defended his Master thesis: “Screening of new potential inhibitors against chitin synthases using in silico, in vitro, and in vivo approaches” Today, ...